betaine has been researched along with clofibric acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Moerkerk, HT; Veerkamp, JH | 1 |
| Chambers, ST; Elmslie, JL; Fink, JN; George, PM; Lever, M; Richards, AM; Scott, RS; Slow, S | 1 |
| Davidson, MH | 1 |
| Chambers, ST; Elmslie, JL; George, PM; Lever, M; Scott, RS; Shand, BI; Slow, S | 1 |
1 review(s) available for betaine and clofibric acid
| Article | Year |
|---|---|
Fibrates plus betaine: a winning combination?
Topics: Betaine; Clofibric Acid; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipotropic Agents; Treatment Outcome | 2010 |
1 trial(s) available for betaine and clofibric acid
| Article | Year |
|---|---|
Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine.
Topics: Acute Coronary Syndrome; Aged; Betaine; Clofibric Acid; Cohort Studies; Diabetes Complications; Female; Homocysteine; Humans; Hypolipidemic Agents; Lipids; Male; S-Adenosylmethionine; Stroke | 2009 |
2 other study(ies) available for betaine and clofibric acid
| Article | Year |
|---|---|
Effect of various agents and conditions on palmitate oxidation by homogenates of rat liver and rat and human skeletal muscle.
Topics: Animals; Antimycin A; Betaine; Carbon Radioisotopes; Carnitine; Clofibric Acid; Cyanates; Fatty Acids; Humans; Liver; Malonyl Coenzyme A; Mitochondria, Liver; Mitochondria, Muscle; Muscles; Oxidation-Reduction; Palmitic Acid; Palmitic Acids; Rats | 1985 |
A clinical puzzle: fibrates and homocysteine elevation: editorial to: "fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine" by M. Lever et al.
Topics: Animals; Betaine; Bezafibrate; Clofibric Acid; Dyslipidemias; Folic Acid; Homocysteine; Humans; Hypolipidemic Agents; Metabolic Syndrome | 2009 |